tiprankstipranks
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Financial Statements

485 Followers

Athira Pharma Financial Overview

Athira Pharma's market cap is currently ―. The company's EPS TTM is $-3.048; its P/E ratio is -0.84; Athira Pharma is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -26.34M-$ -32.97M$ -29.60M$ -27.98M
EBITDA$ -26.30M-$ -33.07M$ -29.71M$ -28.02M
Net Income Common Stockholders$ -26.30M$ -27.55M$ -32.97M$ -29.60M$ -27.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.09M$ 147.42M$ 172.95M$ 186.09M$ 185.98M
Total Assets$ 133.46M$ 160.25M$ 184.70M$ 208.05M$ 232.77M
Total Debt$ 1.50M$ 1.58M$ 1.67M$ 1.75M$ 1.83M
Net Debt$ -120.59M$ -145.83M$ -171.28M$ -184.34M$ -184.15M
Total Liabilities$ 26.72M$ 30.06M$ 29.94M$ 23.07M$ 21.65M
Stockholders Equity$ 106.74M$ 130.19M$ 154.76M$ 184.98M$ 211.13M
Cash Flow-
Free Cash Flow$ -25.81M-$ -24.01M$ -24.32M$ -26.43M
Operating Cash Flow$ -25.80M$ -26.29M$ -23.98M$ -24.28M$ -26.19M
Investing Cash Flow$ 13.04M$ 6.39M$ 20.69M$ 32.49M$ 35.52M
Financing Cash Flow-$ 152.00K-$ 242.00K$ 99.00K
Currency in USD

Athira Pharma Earnings and Revenue History

Athira Pharma Debt to Assets

Athira Pharma Cash Flow

Athira Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis